RNA/DNA immune profiling
Focused immune signatures designed to reveal response-relevant biology in clinically meaningful settings.
MIORG’s technology platform combines molecular profiling, functional immunology, and translational interpretation to support both predictive and therapeutic oncology programs.
Build evidence through layered biology rather than isolated readouts.
Focused immune signatures designed to reveal response-relevant biology in clinically meaningful settings.
Multidimensional interpretation instead of dependence on a single biomarker category.
Support for location-aware immune biology and tumor microenvironment interpretation.
Protein-level insights to complement molecular signatures and pathway hypotheses.
Structured tissue interpretation for translational development and biomarker framing.
Analytical methods to support signal integration, prioritization, and predictive modeling work.
Assays intended to test biological meaning, not only statistical association.
Mechanism-relevant testing tied to antigen presentation and antitumor T-cell generation.
Resistant-model evaluation to support program refinement and combination hypotheses.
MIORG’s platform is not limited to discovery. It is structured to support validation design, partner communication, and clinically meaningful development hypotheses that can translate into diagnostics, combination strategies, or collaboration frameworks.